NIVF vs SRXH

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

NIVF

45.9
AI Score
VS
NIVF Wins

SRXH

40.7
AI Score

Investment Advisor Scores

NIVF

46score
Recommendation
HOLD

SRXH

41score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric NIVF SRXH Winner
Forward P/E 0.0071 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -4.7% -9.4% NIVF
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 45.9/100 40.7/100 NIVF
Profit Margin 24.2% 0.0% NIVF
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

NIVF 1M: -76.8% · 3M: -84.6% SRXH 1M: -37.1% · 3M: -40.6%

Current Technical Phase

NIVF

Markdown
Sell / avoid

Price below a falling SMA50 (slope -34.9%), weak momentum, RSI 40

RSI (14): 39.6 · Price: $0.19

SRXH

Markdown
Sell / avoid

Price below a falling SMA50 (slope -7.7%), weak momentum, RSI 23

RSI (14): 23.3 · Price: $1.07

Fundamentals Snapshot

Metric NIVF SRXH
Market Cap — —
Forward P/E 0.0 0.0
Trailing P/E — 0.0
Revenue (TTM) — —
Revenue Growth 0.0% -0.1%
Gross Margin 0.2% 0.3%
Operating Margin -1.8% -0.9%
EPS -3784.13 66.76
Dividend Yield — 0.00%

Frequently Asked Questions

Based on our detailed analysis, NIVF is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.